VARENICLINE TARTRATE

Generic: VARENICLINE TARTRATE

Glenmark Pharmaceuticals Inc.Manufacturer
ORALRoute
VARENICLINE TARTRATEActive Substance
2023-08-01Original Approval

VARENICLINE TARTRATE is FDA application ANDA214255, sponsored by MANKIND PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
NAUSEA
266 reports
2
DRUG INEFFECTIVE
230 reports
3
DIZZINESS
181 reports
4
DEPRESSION
171 reports
5
HEADACHE
166 reports
6
DYSPNOEA
157 reports
7
ANXIETY
150 reports
8
INSOMNIA
145 reports
9
FATIGUE
140 reports
10
VOMITING
135 reports